Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · IEX Real-Time Price · USD
2.531
+0.031 (1.23%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ARMP stock has a target of 7.00, which predicts an increase of 176.59% from the current stock price of 2.53.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 22, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for ARMP is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 | Strong Buy | Maintains | $7 | +176.59% | Mar 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +176.59% | Aug 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +176.59% | May 12, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +176.59% | Mar 17, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +176.59% | Mar 7, 2023 |
Financial Forecast
Revenue This Year
4.74M
from 4.53M
Increased by 4.73%
Revenue Next Year
2.81M
from 4.74M
Decreased by -40.86%
EPS This Year
-1.36
from -1.91
EPS Next Year
-1.33
from -1.36
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 5.0M | 5.8M | n/a | 6.3M | 57.9M |
| Avg | 4.7M | 2.8M | n/a | 6.1M | 56.3M |
| Low | 4.4M | n/a | n/a | 5.8M | 54.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.3% | 21.8% | - | - | 851.6% |
| Avg | 4.7% | -40.9% | - | - | 824.4% |
| Low | -2.6% | - | - | - | 788.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.30 | -1.35 | -1.09 | -0.44 | -0.08 |
| Avg | -1.36 | -1.33 | -1.06 | -0.43 | -0.08 |
| Low | -1.40 | -1.28 | -1.02 | -0.41 | -0.08 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.